UPDATE: Goldman Sachs Lowers PT on Walgreen Company to $42

Goldman Sachs is out with its report today on Walgreen Company WAG, lowering its PT from $43 to $42. In its report, Goldman Sachs writes, "We cut our 12- month target price to $42 from $43 to reflect a more onerous downside case for WAG/ESRX ESRX, which drives 25% of our risk/reward analysis. Our target price is based on risk/reward and DCF." Goldman Sachs maintains Buy on WAG. At the time of posting, shares of WAG were trading at $35.06, up 0.49% from Friday's close.